Treating sarcopenia in older and oldest old

Current Pharmaceutical Design

Volumn 21, Issue 13, 2015, Pages 1715-1722

  Martone, Anna Maria ^a   Lattanzio, Fabrizia ^b   Abbatecola, Angela Marie ^b   La Carpia, Domenico ^a   Tosato, Matteo ^a   Marzetti, Emanuele ^a   Calvani, Riccardo ^a   Onder, Graziano ^a   Landi, Francesco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b INRCA   (Italy)

Author keywords

Aging; Medications; Nutritional intervention; Physical exercise; Sarcopenia

Indexed keywords

AMINO ACID; AMINO ACID DERIVATIVE; C REACTIVE PROTEIN; CITRULLINE; CREATINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOBOSARM; ESSENTIAL FATTY ACID; GHRELIN; HYDROXY BETA METHYLBUTYRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LEUCINE; LGD 4033; MALIC ACID; MUSCLE PROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ORNITHINE; ORNITHINE OXOGLUTARATE; PRASTERONE; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG; VITAMIN D;

AEROBIC EXERCISE; AGED; ARTICLE; BODY EQUILIBRIUM; BONE DENSITY; DIET SUPPLEMENTATION; HUMAN; INSULIN SENSITIVITY; MUSCLE CELL; MUSCLE MASS; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESISTANCE TRAINING; SARCOPENIA; SKELETAL MUSCLE; STRETCHING EXERCISE; VITAMIN D DEFICIENCY; AGE; VERY ELDERLY;

AGE FACTORS; AGED, 80 AND OVER; HUMANS; SARCOPENIA;

EID: 84930902804     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150130122032     Document Type: Article

References (96)

1. Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactiv-ity. Am J Clin Nutr 2010; 91: 1123S-7S.
2. Morley JE. Anorexia, sarcopenia, and aging. Nutrition 2001; 17:660-3.
3. Morley JE, Abbatecola AM, Argiles JM, et al. Society on Sarco-penia, Cachexia and Wasting Disorders Trialist Workshop. Sarco-penia with limited mobility: an international consensus. J Am MedDir Assoc 2011; 12: 403-9
4. Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor forfalls in elderly individuals: Results from the ilSIRENTE study. ClinNutr 2012; 31: 652-8
5. Evans WJ, Cyr-Campbell D. Nutrition, exercise, and healthy aging. J Am Diet Assoc 1997; 97: 632-8
6. Madsen OR, Lauridsen UB, Hartkopp A, Sørensen OH. Musclestrength and soft tissue composition as measured by dual energy x-ray absorptiometry in women aged 18-87 years. Eur J Appl PhysiolOccup Physiol 1997; 75(3): 239-45.
7. Cesari M, Pedone C, Incalzi RA, Pahor M. ACE-inhibition andphysical function: results from the Trial of Angiotensin-ConvertingEnzyme Inhibition and Novel Cardiovascular Risk Factors(TRAIN) study. J Am Med Dir Assoc 2010; 11: 26-32.
8. Montgomery HE, Marshall R, Hemingway H, et al. Human genefor physical performance. Nature 1998; 393: 221-2.
9. Abbatecola AM, Ferrucci L, Ceda G, et al. Insulin resistance andmuscle strength in older persons. J Gerontol A Biol Sci Med Sci2005; 60: 1278-82.
10. Bean JF, Leveille SG, Kiely DK, et al. A comparison of leg powerand leg strength within the InCHIANTI study: which influencesmobility more? J Gerontol A Biol Sci Med Sci 2003; 58: 728-33.
11. Erim Z, Beg MF, Burke DT, de Luca CJ. Effects of aging on mo-tor-unit control properties. Am Physiol Soc 1999; 82: 2081-91.
12. Marzetti E, Calvani R, Cesari M, et al. Mitochondrial dysfunctionand sarcopenia of aging: from signaling pathways to clinical trials . Int J Biochem Cell Biol 2013; 45: 2288-301.
13. Barbieri M, Ferrrucci L, Emilia R, et al. Chronic inflammation andthe effect of IGF-1 on muscle strength and power in older persons. Am J Physiol Metab 2003; 284: E481-7.
14. Landi F, Abbatecola AM, Provinciali M, et al. Moving againstfrailty: does physical activity matter? Biogerontology 2010; 11:537-45.
15. Frontera WR, Bigard X. The benefits of strength training in theelderly. Sci Sports 2002; 17: 109-116.
16. Frontera WR, Meredith CN, O’Reilly KP, Knuttgen HG, Evans WJ., Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 1988; 64: 1038-44.
17. Landi F, Onder G, Carpenter I, Cesari M, Soldato M, Bernabei R. Physical activity prevented functional decline among frail community-living elderly subjects in an international observational study. J Clin Epidemiol 2007; 60: 518-24.
18. Landi F, Russo A, Cesari M, et al. Walking one hour or more perday prevented mortality among older persons: results from ilSI-RENTE study. Prev Med 2008; 47: 422-6.
19. http://www.health.gov/paguidelines/pdf/paguide.pdf accessed November 28th, 2014.
20. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity andpublic health in older adults: recommendation from the AmericanCollege of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1435-45.
21. Sundell J., Resistance Training Is an Effective Tool against Meta-bolic and Frailty Syndromes. Adv Prev Med 2011: 984683.
22. Frontera WR, Bigard X. The benefits of strength training in theelderly. Sci Sports 2002; 17: 109-116. 21.
23. Frontera WR, Meredith CN, O’Reilly KP, Knuttgen HG, Evans WJ. Strength conditioning in older men: skeletal muscle hypertro-phy and improved function. J Appl Physiol 1988; 64: 1038-44.
24. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training andnutritional supplementation for physical frailty in very elderly peo-ple. N Engl J Med 1994; 330: 1769-75
25. Reid KF, Martin KI, Doros G, et al. Comparative Effects of Lightor Heavy Resistance Power Training for Improving Lower Extrem-ity Power and Physical Performance in Mobility-Limited OlderAdults. J Gerontol A Biol Sci Med Sci 2014 [Epub ahead of print]
26. Russell B, Motlagh D, Ashley WW. Form follows function: howmuscle shape is regulated by work. J Appl Physiol 2000; 88: 1127-32.
27. Klitgaard H, Mantoni M, Schiaffino S, et al. Function, morphologyand protein expression of ageing skeletal muscle: a cross-sectionalstudy of elderly men with different training backgrounds. ActaPhysiol Scand 1990; 140(1): 41-5416.
28. Borst SE., Interventions for sarcopenia and muscle weakness inolder people. Age Ageing 2004; 33: 548-55
29. Fielding RA, LeBrasseur NK, Cuoco A, Bean J, Mizer K, FiataroneSingh MA. High-velocity resistance training increases skeletalmuscle peak power in older women. J Am Geriatr Soc 2002; 50:655-62.
30. Fielding RA, Rejeski WJ, Blair S, et al. LIFE Research Group. TheLifestyle Interventions and Independence for Elders Study: designand methods. J Gerontol A Biol Sci Med Sci 2011; 66: 1226-37.
31. Ottenbacher AJ, Snih SA, Karmarkar A, et al. Routine physicalactivity and mortality in Mexican Americans aged 75 and older. JAm Geriatr Soc 2012; 60: 1085-91.
32. Binder EF, Yarasheski KE, Steger-May K, et al. Effects of progres-sive resistance training on body composition in frail older adults:results of a randomized, controlled trial. J Gerontol A Biol Sci MedSci 2005; 60: 1425-31.
33. Landi F, Cesari M, Onder G, et al. Physical activity and mortalityin frail, community-living elderly patients. J Gerontol A Biol SciMed Sci 2004; 59: 833-7.
34. Rantanen T, Era P, Heikkinen E. Physical activity and the changesin maximal isometric strength in men and women from the age of75 to 80 years. J Am Geriatr Soc 1997; 45: 1439-45.
35. Ettinger WH, Burns R, Messier SP, et al. The Fitness Arthritis andSeniors Trial (FAST): a randomized trial comparing aerobic exer-cise and resistance exercise to a health education program onphysical disability in older people with knee osteoarthritis. JAMA1997; 277: 25-31.
36. Leveille SG, Guralnik JM, Ferrucci L, Langlois JA. Aging success-fully until death in old age: opportunities for increasing active lifeexpectancy. Am J Epidemiol 1999; 149: 654-664
37. Blair SN, Kohl HW, Barlow CE, et al. Changes in physical fitnessand all-cause mortality. A prospective study of healthy and un-healthy men. JAMA 1995; 273: 1093-8.
38. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003; 4: CD000340
39. Penninx B, Messier SP, Rejeski WJ, et al. Physical exercise and theprevention of disability in activities of daily living in older personswith osetoarthrits. Arch Intern Med 2001; 161: 2309-16.
40. Gauchard GC, Gangloff P, Jeandel C, Perrin PP. Influence of regu-lar proprioceptive and bioenergetic physical activities on balancecontrol in elderly women. J Gerontol A Biol Sci Med Sci 2003; 58:M846-50.
41. Geffken D, Cushman M, Burke G et al. Association betweenphysical activity and markers of inflammation in a healthy elderlypopulation. Am J Epidemiol 2001; 153: 242-50
42. Nicklas BJ, Hsu FC, Brinkley TJ, et al. Exercise training andplasma C-reactive protein and interleukin-6 in elderly people. J AmGeriatr Soc 2008; 56: 2045-52.
43. Brinkley TE, Leng X, Miller ME, et al. Chronic inflammation isassociated with low physical function in older adults across multi-ple comorbidities. J Gerontol A Biol Sci Med Sci 2009; 64: 455-61.
44. Lakka TA, Lakka HM, Rankinen T, et al. Effect of exercise train-ing on plasma levels of C-reactive protein in healthy adults: theHERITAGE Family Study. Eur Heart J 2005; 26: 2018-25.
45. Owen N, Leslie E, Salmon J, Fotheringham MJ. Environmentaldeterminants of physical activity and sedentary behavior. ExercSport Sci Rev 2000; 28: 153-8
46. Katzmarzyk PT, Church TS, Craig CL, Bouchard C. Sitting timeand mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc 2009; 41: 998-1005
47. Hamilton MT, Hamilton DG, Zderic TW. The role of low energyexpenditure and sitting on obesity, metabolic syndrome, Type 2diabetes, and cardiovascular disease. Diabetes 2007; 56: 2655-67.
48. Chodzkozajko WJ, Proctor DN, FiataroneSingh MA, Minson CT, Salem GJ, Skinner JS. American College of Sports Medicine posi-tion stand. Exercise and physical activity for older adults. Med SciSports Exer 2009; 41: 1510-30.
49. Morley JE. Anorexia and weight loss in older persons. J GerontolA Biol Sci Med Sci 2003; 58: 131-7.
50. Short KR, Nair KS. The effect of age on protein metabolism. CurrOpin Clin Nutr Metab Care 2000; 8: 89-94.
51. Volpi E, Ferrando A, Yeckel CW, Tipton KD, Wolfe RR. Exoge-nous aminoacids stimulate net muscle protein synthesis in theerderly. J Clin Invest 1998 1; 101: 2000-7.
52. Volpi E, Mittendorfer B, Wolf SE, Wolfe RR. Oral amino acidsstimulate muscle protein anabolism in the elderly despite higherfirst-pass splanchnic extraction. Am J Physiol 1999; 277: E513-20.
53. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR., Aging is associated with diminished accretion of muscleproteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr 2005; 82: 1065-73.
54. Rasmussen BB, Fujita S, Wolfe RR, et al. Insulin resistance ofmuscle protein metabolism in aging. FASEB J 2006; 20: 768-9.
55. Campbell WW, Crim MC, Dallal GE, Young VR, Evans WJ. In-creased protein requirements in elderly people: new data and retro-spective reassessments. Am J Clin Nutr 1994; 60: 501-9.
56. Landi F, Marzetti E, Bernabei R. Perspective: Protein: what kind,how much, when? J Am Med Dir Assoc 2013; 14: 66-7.
57. Arnal MA, Mosoni L, Boirie Y, et al. Protein turnover modifica-tions induced by the protein feeding pattern still persist after theend of the diets. Am J Physiol Endocrinol Metab 2000; 278: E902-9.
58. Elliot TA, Cree MG, Sanford AP, Wolfe RR, Tipton KD. Milkingestion stimulates net muscle protein synthesis following resis-tance exercise. Med Sci Sports Exerc 2006; 38: 667-74.
59. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essentialamino acids in the elderly. Am J Physiol Endocrinol Metab 2006;291: E381-7
60. Holecek M, Muthny T, Kovarik M, Sispera L. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism inwhole body and in selected tissues. Food Chem Toxicol 2009; 47:255-9 67.
61. Eley HL, Russell ST, Tisdale MJ. Mechanism of attenuation ofmuscle protein degradation induced by tumor necrosis factor-alphaand angiotensin II by beta-hydroxy-beta-methylbutyrate. Am JPhysiol Endocrinol Metab 2008; 295: E1417-26
62. Petrovic V, Buzadic B, Korac A, et al. Antioxidative defence al-terations in skeletal muscle during prolonged acclimation to cold:role of L-arginine/NO producing pathway. J Exp Biol 2008; 211:114-20.
63. Walrand S. Ornthine alpha-ketoglutarate: colud it be a new thera-peutic option for sarcopania? J Nutr Health Aging 2010; 14: 570-7.
64. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003; 6: 295-9.
65. Simopoulos AP. The importance of the ratio of omega-6/omega-3essential fatty acids. Biomed Pharmacother 2002; 56: 365-79.
66. Robinson SM, Jameson KA, Batelaan SF, et al. Hertfordshire Co-hort Study Group. Diet and its relationship with grip strength incommunity-dwelling older men and women: the Hertfordshire co-hort study. J Am Geriatr Soc 2008; 56(1): 84-90.
67. Montero-Odasso M, Duque G. Vitamin D in the aging muscu-loskeletal system: an authentic strength preserving hormone. MolAspects Med 2005; 26: 203-19.
68. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency,muscle function, and falls in elderly people. Am J Clin Nutr 2002;75: 611-5.
69. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D pre-vents muscular atrophy and reduces falls and hip fractures inwomen after stroke: a randomized controlled trial. Cerebrovasc Dis2005; 20: 187-92.
70. Bischoff HA, Stähelin HB, Dick W, et al. Effects of vitamin D andcalcium supplementation on falls: a randomized controlled trial. JBone Miner Res 2003; 18: 343-51
71. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fallprevention with supplemental and active forms of vitamin D: ameta-analysis of randomised controlled trials. BMJ 2009; 339:b3692
72. Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors ofsarcopenia among nursing home older residents. J Gerontol A BiolSci Med Sci 2012; 67: 48-55.
73. Vescovo G, Dalla Libera L, Serafini F, et al. Improved exercisetolerance after losartan and enalapril in heart failure: correlationwith changes in skeletal muscle myosin heavy chain composition. Circulation 1998; 98: 1742-9.
74. Kranzhöfer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kübler W. Angiotensin induces inflammatory activation of human vascularsmooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19:1623-9.
75. Giovannini S, Marzetti E, Borst SE, Leeuwenburgh C. Modulationof GH/IGF-1 axis: potential strategies to counteract sarcopenia inolder adults. Mech Ageing Dev 2008; 129: 593-601.
76. Di Bari M, van de Poll-Franse LV, Onder G, et al; Health, Agingand Body Composition Study. Antihypertensive medications anddifferences in muscle mass in older persons: the Health, Aging andBody Composition Study. J Am Geriatr Soc 2004; 52: 961-6.
77. Sumukadas D, Witham MD, Struthers AD, McMurdo ME. Effectof perindopril on physical function in elderly people with func-tional impairment: a randomized controlled trial. CMAJ 2007; 177:867-74.
78. Aoki C, Nakano A, Tanaka S, et al. Fluvastatin upregulates endo-thelial nitric oxide synthase activity via enhancement of its phos-phorylation and expression and via an increase in tetrahydrobiop-terin in vascular endothelial cells. Int J Cardiol 2012; 156: 55-6193.
79. Olivieri F, Mazzanti I, Abbatecola AM, et al. Telomere/Telomerasesystem: a new target of statins pleiotropic effect? Curr Vasc Phar-macol 2012; 10: 216-24.
80. Armitage J, Bowman L, Collins R, Parish S, Tobert J., MRC/BHFHeart Protection Study Collaborative Group. Effects of simvastatin40 mg daily on muscle and liver adverse effects in a 5-year ran-domized placebo-controlled trial in 20, 536 high-risk people. BMCClin Pharmacol 2009; 31; 9: 6
81. Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle functionand falls risk in community-dwelling older adults. QJM 2009; 102:625-3399.
82. Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ., Differential anabolic effects of testosterone and aminoacid feeding in older men. J Clin Endocrinol Metab 2003; 88: 358-62.
83. Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects oftestosterone on muscle strength, physical function, body composi-tion, and quality of life in intermediate-frail and frail elderly men: arandomized, double-blind, placebo-controlled study. J Clin Endo-crinol Metab 2010; 95: 639-50.
84. Borst SE, Yarrow JF, Conover CF, et al. Musculoskeletal andprostate effects of combined testosterone and finasteride admini-stration in older hypogonadal men: a randomized, controlled trial. Am J Physiol Endocrinol Metab 2014 15; 306: E433-42.
85. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone(DHEA), DHEA sulfate, and aging: contribution of the DHEAgeStudy to a sociobiomedical issue. Proc Natl Acad Sci USA 2000;97: 4279-84
86. Baker WL, Karan S, Kenny AM. Effect of dehydroepiandrosteroneon muscle strength and physical function in older adults: a system-atic review. J Am Geriatr Soc 2011; 59: 997-1002.
87. Tai K, Visvanathan R, Hammond AJ, Wishart JM, Horowitz M, Chapman IM. Fasting ghrelin is related to skeletal muscle mass inhealthy adults. Eur J Nutr 2009; 48: 176-83 108.
88. Morley JE, Argiles JM, Evans WJ, et al; Society for Sarcopenia,Cachexia, and Wasting Disease. Nutritional recommendations forthe management of sarcopenia. J Am Med Dir Assoc 2010; 11:391-6.
89. Aguiar AF, Januário RS, Junior RP, et al. Long-term creatine sup-plementation improves muscular performance during resistancetraining in older women. Eur J Appl Physiol 2013; 113: 987-96.
90. Cooke MB, Brabham B, Buford TW, et al. Creatine supplemen-tation post-exercise does not enhance training-induced adaptationsin middle to older aged males. Eur J Appl Physiol 2014; 114: 1321-32.
91. Onder G, Della Vedova C, Landi F. Validated treatments andtherapeutics prospectives regarding pharmacological products forsarcopenia. J Nutr Health Aging 2009; 13: 746-56.
92. Bhasin S, Jasuja R. Selective androgen receptor modulators asfunction promoting therapies. Curr Opin Clin Nutr Metab Care2009; 12: 232-40.
93. Mohler ML, Bohl CE, Jones A, et al. Nonsteroidal selective andro-gen receptor modulators (SARMs): dissociating the anabolic andandrogenic activities of the androgen receptor for therapeutic bene-fit. J Med Chem 2009; 52: 3597-617.
94. Dalton J, Barnette K, Bohl C, et al. The selective androgen receptormodulator GTx-024 (enobosarm) improves lean body mass andphysical function in healthy elderly men and postmenopausalwomen: results of a double-blind, placebo-controlled phase II trial . J Cachexia Sarcopenia Muscle 2011; 2: 153-61.
95. Papanicolaou DA, Ather SN, Zhu H, et al. A phase IIA random-ized, placebo-controlled clinical trial to study the efficacy andsafety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging2013; 17: 533-43.
96. Basaria S, Collins L, Dillon EL, et al. The safety, pharmacokinet-ics, and effects of LGD-4033, a novel nonsteroidal oral, selectiveandrogen receptor modulator, in healthy young men. J Gerontol ABiol Sci Med Sci 2013; 68: 87-95.